Market Place
Sourcing Support
All News #Library
Biotech
Myrtelle Publishes Interim Phase 1/2 Results of rAAV-Olig001-ASPA
01 Oct 2025 //
GLOBENEWSWIRE
Myrtelle Publishes Interim Ph 1/2 rAAV-Olig001-ASPA Data
16 Sep 2025 //
PR NEWSWIRE
Myrtelle, Charles River, Viralgen Team on Canavan Therapy
09 Jul 2025 //
PR NEWSWIRE
Myrtelle Reports NAA Reduction In Canavan Disease Gene Therapy
10 Oct 2024 //
BUSINESSWIRE
Myrtelle: FDA Selects rAAV-Olig001-ASPA For Canavan START Program
05 Jun 2024 //
PR NEWSWIRE
Myrtelle Announces Presentation of Data in Study of rAAV-Olig001-ASPA
10 Oct 2023 //
BUSINESSWIRE
Myrtelle to Present Positive Post-Treatment Data in Study of rAAV-Olig001-ASPA
31 May 2023 //
BUSINESSWIRE
Myrtelle Announces Positive Data in Phase 1/2 Trial of rAAV-Olig001-ASPA
09 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.